View webinar again. Download transcript. Please contact us for a copy of the slides.
Webinar - 27th April 2010 Drug Metabolism Considerations in Drug Safety Assessment.
Expediting IV/PK studies with Microtracers
Analysis of quinolone-resistant streptococcus pneumoniae collected from PROTEKT studies between 2000 and 2007
Molecular characterization of penicillin-binding-protein-3 in clinical isolates of Haemophilus influenzae with reduced susceptibility to cefotaxime, taken from the British Society for Antimicrobial Chemotherapy respiratory resistance surveillance study
Characterization of a high-level telithromycin-resistant clinical isolate of streptococcus pneumoniae collected from the PROTEKT US surveillance study years 1-6
Biosimilars: A transatlantic drift?
FDA metabolite safety testing guidelines: The mist clears
Use of scintigraphic imaging to enhance decision making capabilities in formulation design space studies
Biomarkers in Rheumatoid Arthritis
Validation of an immunoasay for the determination of leukotriene B4 in human sputum supernatant